In the clinical setting, the blockade of PD-1 resulted in increased proliferation and enhanced suppressive function of tumor-infiltrating T regs resulting in rapid tumor progression in 10% of advanced gastric cancer patients [39]. The gene discussed is PDCD1; the disease is neoplasm.